Skip to main content

Table 1 Patients demographics

From: Efficacy of 4′-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study

Demographics

Number

Patients

26

Sex, male

23

Mean age years (standard deviation)

66.4 (9.7)

Location

 Upper

7

 Middle

14

 Lower

5

Clinical T-stage

 cT2

2

 cT3

13

 cT4

11

Clinical N-stage

 cN0

6

 cN1

6

 cN2

13

 cN3

1

Neoadjuvant therapy

 Chemotherapy

14

 Chemoradiotherapy

12

Tumor marker

 SCC (ng/mL) [median, (range)]

2.2 (0.6, 8.1)

 CEA (ng/mL) [median, (range)]

2.2 (0.2, 8.6)